Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight research firms that are currently covering the stock, Marketbeat ...
Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies MOUNTAIN VIEW, Calif., Nov. 04 ...
After hours: January 3 at 6:32:13 PM EST Loading Chart for IGMS ...
After hours: 7:37:51 p.m. EST ...
The NBER endeavors to make its web content accessible to all. To request an accessible version of a Working Paper, please contact webaccessibility@nber.org and one will be provided within 5 business ...
Germany’s economy remains in crisis, and economic analysts do not have high hopes for 2025, either. Industry continues to suffer from geopolitical conflicts, which are putting the dampers on global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback